Form D · Other
Oncologic, Inc. / DE
Orlando, FL · CIK 0002148177
Offering snapshot reported Aug 5, 2026 · SEC filing
- Reported sold
- $26.7M Offering amount: $26.7M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2026 | Initial | $26,749,995 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593155
$6,750,000.00 of the Total Amount Sold was purchased through the conversions of Simple Agreements for Future Equity.
Source: Form D, filed Aug 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Willem Britz | Executive |
| Clynt Taylor | Executive |
| Chakravarthy Toleti | Director, Executive |
| Sireesha Toleti | Director |
Issuer details
Industry: Other (See others in industry)
Address:
7300 Sand Lake Commons Boulevard Suite 327
Orlando, FL, 32819
Orlando, FL, 32819